NCT07717463 Pericapsular Nerve Group Block Versus Femoral Nerve Block Study
| NCT ID | NCT07717463 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Taksim Egitim ve Arastirma Hastanesi |
| Condition | Hip Fractures |
| Study Type | INTERVENTIONAL |
| Enrollment | 110 participants |
| Start Date | 2026-07-22 |
| Primary Completion | 2026-12-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 110 participants in total. It began in 2026-07-22 with a primary completion date of 2026-12-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hip fractures are common in older adults and are often associated with severe pain, making it difficult for patients to sit for spinal anesthesia before surgery. Peripheral nerve blocks may improve pain control and facilitate patient positioning, but it remains uncertain whether the Pericapsular Nerve Group (PENG) block provides advantages over the traditional femoral nerve block during the spinal anesthesia procedure.
Eligibility Criteria
Inclusion Criteria: * Adults aged 50 years or older. * Diagnosis of proximal femoral fracture. * Scheduled to undergo surgical repair under spinal anesthesia. * American Society of Anesthesiologists (ASA) physical status I-III. * Able to provide written informed consent. Exclusion Criteria: * Refusal to participate or inability to provide informed consent. * Coagulopathy or contraindication to spinal anesthesia or peripheral nerve block. * Local infection at the planned injection site. * Known allergy or hypersensitivity to local anesthetics. * Pre-existing neurological disease affecting lower extremity function or sensory assessment. * Cognitive impairment preventing reliable study participation or outcome assessment. * Previous lumbar spine surgery. * Polytrauma. * Body mass index (BMI) \<18 kg/m² or \>40 kg/m². * Current anticoagulant therapy that precludes neuraxial anesthesia or peripheral nerve block according to institutional practice.
Contact & Investigator
Celal Kaya
PRINCIPAL INVESTIGATOR
Taksim Training and Research Hospital
Frequently Asked Questions
Who can join the NCT07717463 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Hip Fractures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07717463 currently recruiting?
Yes, NCT07717463 is actively recruiting participants. Contact the research team at c.kaya47@hotmail.com for enrollment information.
Where is the NCT07717463 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye), Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07717463 clinical trial?
NCT07717463 is sponsored by Taksim Egitim ve Arastirma Hastanesi. The principal investigator is Celal Kaya at Taksim Training and Research Hospital. The trial plans to enroll 110 participants.